These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26086305)

  • 1. Savvy Sellers: Dealing Drugs, Doing Gender, and Doing Difference.
    Ludwick MD; Murphy S; Sales P
    Subst Use Misuse; 2015 May; 50(6):708-20. PubMed ID: 26086305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Sales, Gender, and Risk: Notions of Risk From the Perspective of Gang-Involved Young Adults.
    Moloney M; Hunt G; Joe-Laidler K
    Subst Use Misuse; 2015 May; 50(6):721-32. PubMed ID: 25774919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit sale of pharmaceuticals in Africa: sellers and clients in the suburbs of Dakar.
    Fassin D
    Trop Geogr Med; 1988 Apr; 40(2):166-70. PubMed ID: 3407009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs, Gender, and Prohibition: A Comment on a Focus on Gender in the Drugs Field With Particular Reference to the Works of Micheline D. Ludwick, Sheigla Murphy, and Paloma Sales; Jody Miller and Kristin Carbone-Lopez; and Molly Moloney, Geoffrey Hunt, and Karen Joe-Laidler.
    Klein A
    Subst Use Misuse; 2015 May; 50(6):733-5. PubMed ID: 26086306
    [No Abstract]   [Full Text] [Related]  

  • 6. "Selling smarter, not harder": Life course effects on drug sellers' risk perceptions and management.
    Fader JJ
    Int J Drug Policy; 2016 Oct; 36():120-9. PubMed ID: 27450317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demand and Supply Motivations for Antiretroviral Drugs in Illicit Street Markets: The Case of Atlanta, Georgia.
    Saravia A; Mueller R
    AIDS Behav; 2019 Aug; 23(8):2079-2087. PubMed ID: 30535835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seller's reputation and capacity on the illicit drug markets: 11-month study on the Finnish version of the Silk Road.
    Nurmi J; Kaskela T; Perälä J; Oksanen A
    Drug Alcohol Depend; 2017 Sep; 178():201-207. PubMed ID: 28654873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond 'Doing Gender': Incorporating Race, Class, Place, and Life Transitions into Feminist Drug Research.
    Miller J; Carbone-Lopez K
    Subst Use Misuse; 2015 May; 50(6):693-707. PubMed ID: 25723310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid drug dealing: Merging on- and offline spheres when dealing drugs via social media.
    Korshøj NT; Søgaard TF
    Int J Drug Policy; 2024 Aug; 130():104509. PubMed ID: 38968672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking Care of Business in a Male - Dominated Drug Economy: Income Strategies, Risks, and Opportunities of Women Who Use Drugs.
    Richert T
    Front Psychiatry; 2022; 13():882128. PubMed ID: 35656345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion and diversion of suboxone: an exploration of illicit street opioid selling.
    Furst RT
    J Addict Dis; 2014; 33(3):177-86. PubMed ID: 25115236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicine sellers' perspectives on their role in providing health care in North-West Cameroon: a qualitative study.
    Hughes R; Chandler CR; Mangham-Jefferies LJ; Mbacham W
    Health Policy Plan; 2013 Sep; 28(6):636-46. PubMed ID: 23197432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug sellers' neutralizations of guiltless drug sales and avoidance of "drug dealer" identities.
    Dickinson T; Jacques S
    Int J Drug Policy; 2019 Nov; 73():16-23. PubMed ID: 31330275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highs and lows of drug decriminalisation.
    Hawkes N
    BMJ; 2011 Oct; 343():d6881. PubMed ID: 22031913
    [No Abstract]   [Full Text] [Related]  

  • 19. Gun carrying and drug selling among young incarcerated men and women.
    Kacanek D; Hemenway D
    J Urban Health; 2006 Mar; 83(2):266-74. PubMed ID: 16736375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand.
    Wilkins C; Reilly JL; Casswell S
    Addiction; 2005 Jul; 100(7):971-80. PubMed ID: 15955013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.